Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 7, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Starting a carotid artery stenting program is safe.

Marco Roffi1, Matthias Greutmann, Franz R Eberli

  • 1Department of Cardiology, University Hospital, Zurich, Switzerland. marco.roffi@usz.ch

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|March 1, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Trends and Outcomes in Transcatheter Aortic Valve Implantation: a report from the SwissTAVI Registry.

Cardiovascular intervention and therapeutics·2026
Same author

SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.

JACC. Asia·2026
Same author

Stent retriever-assisted coronary thrombectomy with continuous aspiration.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Carotid artery stenting in asymptomatic disease: a new paradigm.

European heart journal·2026
Same author

Impact of total stent length on long-term outcomes with different newer-generation drug-eluting stent designs in ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI ES randomized trial.

American heart journal·2026
Same author

Forensic Diagnosis of Sudden Cardiac Death Due to Thrombosis Secondary to Coronary Artery Ectasia: A Description of Two Cases.

Cureus·2026

Newly initiated carotid artery stenting (CAS) programs can be safe and effective when led by fellowship-trained specialists. This study shows low major adverse event rates in the first 100 patients treated.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Neurology

Background:

  • Performance of new carotid artery stenting (CAS) programs is largely unknown.
  • Safety concerns arise from prior studies with limited interventional experience requirements.

Purpose of the Study:

  • To evaluate the safety and outcomes of a newly established academic CAS program.
  • To report the initial experience of the first 100 consecutive patients undergoing CAS.

Main Methods:

  • Prospective data collection of patient outcomes in a new CAS program.
  • All procedures performed by a CAS-fellowship-trained interventionalist.
  • Assessment of 30-day major adverse events (MAE) including death, stroke, and myocardial infarction.

Related Experiment Videos

Last Updated: Jul 7, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Main Results:

  • The 30-day MAE rate per procedure was 1.9% (one major, one minor stroke).
  • At a mean follow-up of 16 months, total MAE per patient was 4%, with a 7% rate of any stroke or death.
  • Restenosis rate of >=50% per lesion was 3.8% by ultrasound.

Conclusions:

  • A newly initiated CAS program can be safely established with dedicated fellowship training.
  • This single-center experience supports the safety of starting CAS programs with specialized training.